Cypre

San Francisco, United States

Cypre Inc. is a biotechnology company developing novel 3D in vitro models of the tumor microenvironment (TME) for cancer drug discovery.

$875K raised

Oct 2022

Convertible Note

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Cypre

How much funding has Cypre raised?

Cypre has raised $875K in total funding. The most recent round was Convertible Note. The last funding was announced in October 2022.

Where is Cypre headquartered?

Cypre is headquartered in San Francisco, United States.

What does Cypre do?

Cypre Inc. is a biotechnology company developing novel 3D in vitro models of the tumor microenvironment (TME) for cancer drug discovery.

What stage is Cypre at?

Cypre is at the Convertible Note stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 22, 2022.

MLA

"Cypre — Funding & Investors." VCBacked, October 22, 2022, https://www.vcbacked.co/company/cypre. Accessed July 3, 2026.

APA

VCBacked. (2022). Cypre — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/cypre

Wikipedia (cite web)

{{cite web |title=Cypre — Funding & Investors |url=https://www.vcbacked.co/company/cypre |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 22, 2022.